BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8226566)

  • 41. Advances in management of low-risk febrile neutropenia.
    Teuffel O; Sung L
    Curr Opin Pediatr; 2012 Feb; 24(1):40-5. PubMed ID: 22037219
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness of outpatient management for febrile neutropenia in children with cancer.
    Teuffel O; Amir E; Alibhai SM; Beyene J; Sung L
    Pediatrics; 2011 Feb; 127(2):e279-86. PubMed ID: 21220399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibiotics and growth factors in the management of fever and neutropenia in cancer patients.
    Garcia-Carbonero R; Paz-Ares L
    Curr Opin Hematol; 2002 May; 9(3):215-21. PubMed ID: 11953667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Consensus on management of children with cancer, neutropenia and fever: Update 2008-2009].
    Comité Nacional de Infectología Pediátrica
    Arch Argent Pediatr; 2010 Apr; 108(2):e47-70. PubMed ID: 20467701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and laboratory features predicting a favorable outcome and allowing early discharge in cancer patients with low-risk febrile neutropenia: a literature review.
    Castagnola E; Paola D; Giacchino R; Viscoli C
    J Hematother Stem Cell Res; 2000 Oct; 9(5):645-9. PubMed ID: 11091488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is it time to redefine the management of febrile neutropenia in cancer patients?
    Anaissie EJ; Vadhan-Raj S
    Am J Med; 1995 Mar; 98(3):221-3. PubMed ID: 7872336
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of risk stratification to guide ambulatory management of neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee.
    Worth LJ; Lingaratnam S; Taylor A; Hayward AM; Morrissey S; Cooney J; Bastick PA; Eek RW; Wei A; Thursky KA;
    Intern Med J; 2011 Jan; 41(1b):82-9. PubMed ID: 21272172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early discharge of low-risk febrile neutropenic children and adolescents with cancer.
    Aquino VM; Tkaczewski I; Buchanan GR
    Clin Infect Dis; 1997 Jul; 25(1):74-8. PubMed ID: 9243037
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pathophysiology and diagnosis of cancer patients with febrile neutropenia].
    Saito T; Aiba K
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):684-7. PubMed ID: 23863643
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outpatient therapy for febrile neutropenia: clinical and economic implications.
    de Lalla F
    Pharmacoeconomics; 2003; 21(6):397-413. PubMed ID: 12678567
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neutropenic fever and sepsis: evaluation and management.
    Rolston KV
    Cancer Treat Res; 2014; 161():181-202. PubMed ID: 24706225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nursing protocol for the patient with neutropenia.
    Brandt B
    Oncol Nurs Forum; 1990; 17(1 Suppl):9-15. PubMed ID: 2105483
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early discharge and ambulatory care of low-risk patients with neutropenic fever in Australia.
    Hocking C; Taylor A; Hayward A
    Intern Med J; 2013 May; 43(5):591-5. PubMed ID: 23668271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early empiric antibiotic therapy for febrile neutropenia patients at low risk.
    Rolston KV; Rubenstein EB; Freifeld A
    Infect Dis Clin North Am; 1996 Jun; 10(2):223-37. PubMed ID: 8803619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Strategies of treatment for febrile neutropenia].
    Terui Y
    Gan To Kagaku Ryoho; 2013 Jun; 40(6):688-92. PubMed ID: 23863644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety of discharge for children with cancer and febrile neutropenia off antibiotics using absolute neutrophil count threshold values as a surrogate marker for adequate bone marrow recovery.
    Campbell ME; Friedman DL; Dulek DE; Zhao Z; Huang Y; Esbenshade AJ
    Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Febrile neutropenia in children.
    Crokaert F
    Int J Antimicrob Agents; 2000 Oct; 16(2):173-6. PubMed ID: 11053804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Special features of febrile neutropenia in pediatric patients].
    Olivé-Oliveras MT; Ruiz-Camps I
    Enferm Infecc Microbiol Clin; 2005 Dec; 23 Suppl 5():35-9. PubMed ID: 16857155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New trends in patient management: risk-based therapy for febrile patients with neutropenia.
    Rolston KV
    Clin Infect Dis; 1999 Sep; 29(3):515-21. PubMed ID: 10530438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Management of low-risk febrile patients with neutropenia].
    Batlle M; Lloveras N
    Enferm Infecc Microbiol Clin; 2005 Dec; 23 Suppl 5():30-4. PubMed ID: 16857154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.